Ok. Ok. Why all the negativity? To all the Otsuka and Sunovion posters on this thread, we are all well aware of our situation. It's not that big of a deal.
If our aripiprazole compound is delayed for another 4 to 6 weeks it really isn't a big deal. Our management has been very honest with us. If it doesn't get approved then we look for new jobs.
As for the pipeline here, it is great. The MDD drug is going to be the biggie. None of us came here to sell the aripiprazole compound. It will be a difficult sale, but it does have some advantages and will be a good lead in to the two great compounds that should be approved in 18 to 24 months. Management has assured us that we will be kept. If we are not kept (aripip. doesn't get approved) I'm sure we will have great severance packages. There is no way this company with its two great compounds coming out soon would not give a great severance because that would make sure no one would ever take the risk to come here to launch the porducts on the way.
Yes, we took a risk coming here. Hopefully aripip will be approved in a month or so. If not, I'll take my severance and find another job.